Literature DB >> 25495498

Safety of olmesartan in a patient with telmisartan-induced myotoxicity: a case report.

Manish J Barvaliya1, Viren N Naik1, Ashok C Shah2, Chandrabhanu R Tripathi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25495498      PMCID： PMC4456137          DOI： 10.1111/bcp.12569

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Myalgia and arthralgia associated with enalapril and ramipril.

Authors:  M P Peppers
Journal:  Am J Health Syst Pharm       Date:  1995-01-15       Impact factor: 2.637

2.  Acute rhabdomyolysis associated with troglitazone.

Authors:  M Yokoyama; Y Izumiya; M Yoshizawa; R Usuda
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

Review 3.  Drug-related myopathies of which the clinician should be aware.

Authors:  Ritu Valiyil; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

4.  Inhibitory effects of angiotensin receptor blockers on CYP2C9 activity in human liver microsomes.

Authors:  Emi Kamiyama; Yasushi Yoshigae; Atsushi Kasuya; Makoto Takei; Atsushi Kurihara; Toshihiko Ikeda
Journal:  Drug Metab Pharmacokinet       Date:  2007-08       Impact factor: 3.614

5.  Fever, myalgia, and arthralgia in a patient on captopril and allopurinol.

Authors:  A Samanta; A C Burden
Journal:  Lancet       Date:  1984-03-24       Impact factor: 79.321

6.  Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists.

Authors:  David V Erbe; Katherine Gartrell; Yan-Ling Zhang; Vipin Suri; Steven J Kirincich; Sarah Will; Mylene Perreault; Suyue Wang; James F Tobin
Journal:  Vascul Pharmacol       Date:  2006-05-16       Impact factor: 5.773

7.  Elevated creatine kinase and myalgia in a patient taking rosiglitazone.

Authors:  Natalie Kennie; Tony Antoniou; Philip Berger
Journal:  Ann Pharmacother       Date:  2007-02-27       Impact factor: 3.154

8.  Pioglitazone-induced acute rhabdomyolysis.

Authors:  Raoudha Slim; Chaker Ben Salem; Michele Zamy; Michele Zami; Michel Biour
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 19.112

9.  Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.

Authors:  Michael Schupp; Jürgen Janke; Ronald Clasen; Thomas Unger; Ulrich Kintscher
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

10.  Phenotype standardization for statin-induced myotoxicity.

Authors:  A Alfirevic; D Neely; J Armitage; H Chinoy; R G Cooper; R Laaksonen; D F Carr; K M Bloch; J Fahy; A Hanson; Q-Y Yue; M Wadelius; A H Maitland-van Der Zee; D Voora; B M Psaty; C N A Palmer; M Pirmohamed
Journal:  Clin Pharmacol Ther       Date:  2014-06-04       Impact factor: 6.875
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.